Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents
Phase of Trial: Phase IV
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections; Rheumatoid arthritis
- Focus Pharmacodynamics
- 15 Jun 2016 Status changed from active, no longer recruiting to completed.
- 04 Nov 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Dec 2015 as per Clinicaltrials.gov.
- 21 Sep 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov record